Your browser doesn't support javascript.
loading
The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases.
Zilli, Thomas; Dirix, Piet; Heikkilä, Reino; Liefhooghe, Nick; Siva, Shankar; Gomez-Iturriaga, Alfonso; Everaerts, Wouter; Otte, François; Shelan, Mohamed; Mercier, Carole; Achard, Vérane; Thon, Kristian; Stellamans, Karin; Moon, Daniel; Conde-Moreno, Antonio; Papachristofilou, Alexandros; Scorsetti, Marta; Gückenberger, Matthias; Ameye, Filip; Zapatero, Almudena; Van De Voorde, Lien; López Campos, Fernando; Couñago, Felipe; Jaccard, Maud; Spiessens, An; Semac, Isabelle; Vanhoutte, Frederik; Goetghebeur, Els; Reynders, Dries; Ost, Piet.
Afiliação
  • Zilli T; Department of Radiation Oncology, Geneva University Hospital, Geneva, Switzerland. Electronic address: thomas.zilli@hcuge.ch.
  • Dirix P; Department of Radiation Oncology, Iridium Kankernetwerk, Antwerp, Belgium; University of Antwerp, Faculty of Medicine and Health Sciences, Antwerp, Belgium.
  • Heikkilä R; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Liefhooghe N; Department of Radiation Oncology, AZ Groeninge, Kortrijk, Belgium.
  • Siva S; Epworth Healthcare and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
  • Gomez-Iturriaga A; Biocruces Health Research Institute, Cruces University Hospital, Barakaldo, Spain.
  • Everaerts W; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
  • Otte F; Department of Radiation Oncology, Jules Bordet Institute and Hôpital Erasme, University Clinics of Brussels, Université Libre de Bruxelles, Brussels, Belgium.
  • Shelan M; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Mercier C; Department of Radiation Oncology, Iridium Kankernetwerk, Antwerp, Belgium; University of Antwerp, Faculty of Medicine and Health Sciences, Antwerp, Belgium.
  • Achard V; Department of Radiation Oncology, Geneva University Hospital, Geneva, Switzerland.
  • Thon K; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Stellamans K; Department of Radiation Oncology, AZ Groeninge, Kortrijk, Belgium.
  • Moon D; Royal Melbourne Clinical School, University of Melbourne, Melbourne, Australia.
  • Conde-Moreno A; Department of Radiation Oncology, Hospital Universitari i Politècnic la Fe, Valencia, Spain.
  • Papachristofilou A; Department of Radiotherapy and Radiation Oncology, University Hospital Basel, Basel, Switzerland.
  • Scorsetti M; Radiotherapy and Radiosurgery Department, Humanitas Clinical and Research Hospital IRCSS, Rozzano, Italy.
  • Gückenberger M; Department of Radiation Oncology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
  • Ameye F; Department of Urology, AZ Maria-Middelares, Ghent, Belgium.
  • Zapatero A; Department of Radiation Oncology, University Hospital La Princesa, Madrid, Spain.
  • Van De Voorde L; Department of Radiation Oncology, AZ St-Lucas, Ghent, Belgium.
  • López Campos F; Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Couñago F; Department of Radiation Oncology, University Hospital Quironsalud, Universidad Europea de Madrid, Madrid, Spain.
  • Jaccard M; Department of Radiation Oncology, Geneva University Hospital, Geneva, Switzerland.
  • Spiessens A; Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium.
  • Semac I; Department of Radiation Oncology, Geneva University Hospital, Geneva, Switzerland.
  • Vanhoutte F; Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium.
  • Goetghebeur E; Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium.
  • Reynders D; Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium.
  • Ost P; Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium. Electronic address: piet.ost@ugent.be.
Eur Urol Focus ; 7(2): 241-244, 2021 03.
Article em En | MEDLINE | ID: mdl-33386290
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Terapia de Salvação Tipo de estudo: Clinical_trials Limite: Humans / Male Idioma: En Revista: Eur Urol Focus Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Terapia de Salvação Tipo de estudo: Clinical_trials Limite: Humans / Male Idioma: En Revista: Eur Urol Focus Ano de publicação: 2021 Tipo de documento: Article